Back to News
Market Impact: 0.35
Bayer Wins St. Louis Roundup Trial, Bolstering Settlement Push
Source: Bloomberg
Legal & LitigationCompany Fundamentals
A St. Louis jury rejected claims by three women who said Bayer AG’s Roundup weedkiller caused their cancers. The verdict supports Bayer’s effort to contain potential costs from tens of thousands of similar US lawsuits, which the company has offered to settle.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
BAYN0.65
More News
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Google Sales Miss Reignites AI Fears, Microsoft Eyes $25B Debt Offering
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Warren urges DOJ criminal probe of Bank of America over anti-money-laundering violations
- Intel plunges on a major guidance miss. What went wrong — and how to proceed